<PAGE> 1
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
1. Name and Address of Reporting Person
VENKATARAMAN, BALAJI
660 Hembree Parkway
Suite 106
Roswell, GA 30076
2. Date of Event Requiring Statement (Month/Day/Year)
05/31/00
3. IRS or Social Security Number of Reporting Person (Voluntary)
4. Issuer Name and Ticker or Trading Symbol
FIRST HORIZON PHARMACEUTICAL CORPORATION
FHRX
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
( ) Director ( ) 10% Owner (X) Officer (give title below) ( ) Other
(specify below)
Vice President and Chief Financial Officer
6. If Amendment, Date of Original (Month/Day/Year)
7. Individual or Joint/Group Filing (Check Applicable Line)
(X) Form filed by One Reporting Person
( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
-----------------------------------------------------------------------------------------------------------------------------------|
Table I -- Non-Derivative Securities Beneficially Owned |
-----------------------------------------------------------------------------------------------------------------------------------|
<S> <C> <C> <C>
1. Title of Security |2. Amount of |3. Ownership |4. Nature of Indirect |
| Securities | Form: | Beneficial Ownership |
| Beneficially | Direct(D) or | |
| Owned | Indirect(I) | |
-----------------------------------------------------------------------------------------------------------------------------------|
No securities owned. | | | |
-----------------------------------------------------------------------------------------------------------------------------------|
-----------------------------------------------------------------------------------------------------------------------------------|
</TABLE>
Table II -- Derivative Securities Beneficially Owned
<TABLE>
<CAPTION>
-----------------------------------------------------------------------------------------------------------------------------------|
<S> <C> <C> <C> <C> <C> <C>
1. Title of Derivative |2. Date Exer- |3. Title and Amount | |4. Conver- |5. Owner- |6. Nature of Indirect |
Security | cisable and | of Underlying | |sion or |ship | Beneficial Ownership |
| Expiration | Securities | |exercise |Form of | |
| Date(Month/ |-----------------------|---------|price of |Deriv- | |
| Day/Year) | |Amount |deri- |ative | |
| Date | Expira- | |or |vative |Security: | |
| Exer- | tion | Title |Number of|Security |Direct(D) or | |
| cisable | Date | |Shares | |Indirect(I) | |
-----------------------------------------------------------------------------------------------------------------------------------|
Incentive Stock Option |(1) |9-1-09 |Common Stock |40,000 |$1.88 |D | |
-----------------------------------------------------------------------------------------------------------------------------------
Incentive Stock Option |(2) |10-22-09 |Common Stock |60,000 |1.88 |D | |
-----------------------------------------------------------------------------------------------------------------------------------
Incentive Stock Option |(2) |10-22-09 |Common Stock |100,000 |2.65 |D | |
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
Explanation of Responses:
(1) Option vests in 25% increments beginning on 9-1-99 and 25% per year on the
next 3 anniversaries thereof.
(2) Option vests in 25% increments beginning on 10-22-00 and 25% per year on
the next 3 anniversaries thereof.
SIGNATURE OF REPORTING PERSON
BALAJI VENKATARAMAN
DATE
May 31, 2000
